MANKIND:NSE
Mankind Pharma Ltd
₹2,270.10
arrow_upward
+1.42%(+31.70) 1D
Sep 11, 3:30:00 PM GMT+5:30 · INR
search
All symbols
1D
5D
1M
6M
YTD
1Y
5Y
MAX
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for MANKIND...
Open
₹2,237.20
High
₹2,280.00
Low
₹2,222.00
Mkt. cap
938.22B
Avg. vol.
0.00
Volume
530.70K
P/E ratio
45.93
52-wk high
₹2,674.00
52-wk low
₹1,909.70
EPS
₹49.42
No. of employees
20K
Open
₹2,237.20
High
₹2,280.00
Low
₹2,222.00
Mkt. cap
938.22B
Avg. vol.
0.00
Volume
530.70K
P/E ratio
45.93
52-wk high
₹2,674.00
52-wk low
₹1,909.70
EPS
₹49.42
No. of employees
20K
Profile
Mankind Pharma is an Indian multinational pharmaceutical and healthcare product company, headquartered in Delhi. The company has products in therapeutic areas ranging from antibiotics, to gastrointestinal, cardiovascular, dermal, and erectile dysfunction medications.
As of 2023, Mankind Pharma had 25 factories and 6 R&D centres in India. The company derived 97% of its operating revenue from the Indian market, where it is reportedly the fourth largest pharmaceutical company by domestic sales. Some of Mankind Pharma's consumer healthcare brands are the largest-selling in their respective categories, including Manforce in condoms, Prega News in pregnancy test kits, and Unwanted-72 in emergency contraception. Wikipedia
About Mankind Pharma Ltd
CEORajeev Juneja | Sheetal Arora
Employees20.5K
Founded1991
Headquarters-
SectorPharmaceutical industry
Websitemankindpharma.com